HP Shares Plunge In Wednesday Pre-Market After Weak Q4 Projections
HP Shares Plunge In Wednesday Pre-Market After Weak Q4 Projections
Shares of HP Inc. (NYSE:HPQ) experienced a significant decline, falling by 8.08% in pre-market trading on Wednesday, following the release of its fourth-quarter projections that failed to meet market expectations.
惠普股票（紐交所：HPQ）在週三的美股盤前交易中出現了大幅下跌，下跌了8.08%，原因是發佈了第四季度預測，未能達到市場預期。
HP Inc. reported earnings of $0.93 per share, which aligned with analyst expectations. Revenue reached $14.05 billion, surpassing the consensus estimate of $13.99 billion and marking an increase from the previous year's $13.82 billion, according to Benzinga Pro.
惠普報告每股盈利爲0.93美元，與分析師預期一致。營業收入達到140.5億美元，超過了139.9億美元的共識估計，較上一年的138.2億美元有所增加，根據Benzinga Pro的數據。
Despite the revenue beat, HP's earnings forecast for the fiscal first quarter fell short of analyst predictions. The company anticipates earnings, excluding certain items, to range between 70 cents and 76 cents per share, while analysts expected 86 cents, as per Bloomberg data. For the fiscal year, HP projects profits between $3.45 and $3.75 per share, compared to the average estimate of $3.60.
儘管營收超出預期，惠普財年第一季度的盈利預測低於分析師的預測。該公司預計，不包括某些項目在內，每股盈利區間爲70美分至76美分，而分析師預期爲86美分，根據彭博數據。對於整個財年，惠普預計每股利潤在3.45美元至3.75美元之間，與3.60美元的平均預期相比。
Enrique Lores, HP's CEO, attributed the profit challenges to rising component costs rather than demand issues. He expressed optimism that part prices would decrease over the year.
惠普的CEO Enrique Lores將利潤挑戰歸因於上升的零部件成本而不是需求問題。他表示樂觀情緒，認爲零部件價格會在今年降低。
Meanwhile, as per Benzinga Pro, HP's consensus price target is $33.88, with the highest target of $41 from JP Morgan and the lowest of $30 from Wells Fargo.
與此同時，根據Benzinga Pro的數據，惠普的共識價目標爲33.88美元，最高爲JP摩根的41美元，最低爲富國銀行的30美元。
- Larry Page, Google Co-Founder, Said He'd Leave His Fortune To Elon Musk Over Charity Because Of His Plans 'To Go To Mars To Back Up Humanity'
- Google聯合創始人拉里·佩奇表示，他將把財富留給埃隆·馬斯克，而不是慈善，原因是他計劃「前往火星，以備份人類」。
Disclaimer: This content was partially produced with the help of Benzinga Neuro and was reviewed and published by Benzinga editors.
免責聲明：本內容部分由Benzinga Neuro幫助製作，並經Benzinga編輯審查和發佈。
Image via Shutterstock
圖片來源：shutterstock
譯文內容由第三人軟體翻譯。
